Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy
Marta Guerrero‐Valero, Federica Grandi, Silvia Cipriani, Valeria Alberizzi, Roberta Di Guardo, Gaëtan Chicanne, Linda Sawade, Francesca Bianchi, Ubaldo Del Carro, Ivan de Curtis, Davide Pareyson, Yeşim Parman, Angelo Schenone, Volker Haucke, Bernard Payrastre, Alessandra Bolino
Abstract
Significance Charcot-Marie-Tooth type 4B1 (CMT4B1) is a very severe demyelinating neuropathy with childhood onset, characterized by myelin outfoldings, a pathological aberrant form of myelination. This morphology may be the consequence of an excessive longitudinal growth of the myelinated internode during postnatal nerve development. We first demonstrated that loss of MTMR2 (Myotubularin-related 2) phosphatase causes CMT4B1. MTMR2 dephosphorylates phospholipids, important regulators of membrane trafficking, which is a key process in Schwann cells, the myelinating cells in the PNS. However, why loss of MTMR2 provokes CMT4B1 remains to be assessed. Here we propose a mechanism by which MTMR2, by regulating PtdIns(3,5) P 2 phosphoinositide levels, coordinates myelin synthesis and RhoA/myosin II-dependent cytoskeletal dynamics necessary to expand the membrane and promote myelin growth.